121 related articles for article (PubMed ID: 23248183)
21. Pharmacodynamic immune monitoring of NFAT-regulated genes predicts skin cancer in elderly long-term renal transplant recipients.
Sommerer C; Hartschuh W; Enk A; Meuer S; Zeier M; Giese T
Clin Transplant; 2008; 22(5):549-54. PubMed ID: 18394001
[TBL] [Abstract][Full Text] [Related]
22. A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth.
Streicher KL; Zhu W; Lehmann KP; Georgantas RW; Morehouse CA; Brohawn P; Carrasco RA; Xiao Z; Tice DA; Higgs BW; Richman L; Jallal B; Ranade K; Yao Y
Oncogene; 2012 Mar; 31(12):1558-70. PubMed ID: 21860416
[TBL] [Abstract][Full Text] [Related]
23. The microRNA landscape of cutaneous squamous cell carcinoma.
Konicke K; López-Luna A; Muñoz-Carrillo JL; Servín-González LS; Flores-de la Torre A; Olasz E; Lazarova Z
Drug Discov Today; 2018 Apr; 23(4):864-870. PubMed ID: 29317340
[TBL] [Abstract][Full Text] [Related]
24. Expression of microRNAs in basal cell carcinoma.
Sand M; Skrygan M; Sand D; Georgas D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG
Br J Dermatol; 2012 Oct; 167(4):847-55. PubMed ID: 22540308
[TBL] [Abstract][Full Text] [Related]
25. Chemokine receptor expression in non-melanoma skin cancer.
Basile J; Thiers B; Maize J; Lathers DM
J Cutan Pathol; 2008 Jul; 35(7):623-9. PubMed ID: 18312436
[TBL] [Abstract][Full Text] [Related]
26. [Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer].
Fu XR; Zhang C; Chen CY; Zhang L; Wang LX; Wang BH; Liu XY; Zhang MZ
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):369-73. PubMed ID: 22883459
[TBL] [Abstract][Full Text] [Related]
27. MicroRNAs and cancer--new paradigms in molecular oncology.
Negrini M; Nicoloso MS; Calin GA
Curr Opin Cell Biol; 2009 Jun; 21(3):470-9. PubMed ID: 19411171
[TBL] [Abstract][Full Text] [Related]
28. Identification of novel molecular targets regulated by tumor suppressive miR-1/miR-133a in maxillary sinus squamous cell carcinoma.
Nohata N; Hanazawa T; Kikkawa N; Sakurai D; Sasaki K; Chiyomaru T; Kawakami K; Yoshino H; Enokida H; Nakagawa M; Okamoto Y; Seki N
Int J Oncol; 2011 Nov; 39(5):1099-107. PubMed ID: 21701775
[TBL] [Abstract][Full Text] [Related]
29. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
[TBL] [Abstract][Full Text] [Related]
30. Current trends in miRNAs and their relationship with oral squamous cell carcinoma.
Pérez-Sayáns M; Pilar GD; Barros-Angueira F; Suárez-Peñaranda JM; Fernández AC; Gándara-Rey JM; García-García A
J Oral Pathol Med; 2012 Jul; 41(6):433-43. PubMed ID: 22188431
[TBL] [Abstract][Full Text] [Related]
31. Expression of RUNX3 in skin cancers.
Lee JH; Pyon JK; Kim DW; Lee SH; Nam HS; Kang SG; Kim CH; Lee YJ; Chun JS; Cho MK
Clin Exp Dermatol; 2011 Oct; 36(7):769-74. PubMed ID: 21623876
[TBL] [Abstract][Full Text] [Related]
32. A comparative study of granzyme B expression in keratoacanthoma and squamous cell carcinoma.
Batinac T; Zamolo G; Hadzisejdic I; Zauhar G
J Dermatol Sci; 2006 Nov; 44(2):109-12. PubMed ID: 16952444
[No Abstract] [Full Text] [Related]
33. MicroRNA miR-125b induces senescence in human melanoma cells.
Glud M; Manfé V; Biskup E; Holst L; Dirksen AM; Hastrup N; Nielsen FC; Drzewiecki KT; Gniadecki R
Melanoma Res; 2011 Jun; 21(3):253-6. PubMed ID: 21460750
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA miR-886-5p inhibits apoptosis by down-regulating Bax expression in human cervical carcinoma cells.
Li JH; Xiao X; Zhang YN; Wang YM; Feng LM; Wu YM; Zhang YX
Gynecol Oncol; 2011 Jan; 120(1):145-51. PubMed ID: 20947150
[TBL] [Abstract][Full Text] [Related]
35. MicroRNAs and their target gene networks in renal cell carcinoma.
Redova M; Svoboda M; Slaby O
Biochem Biophys Res Commun; 2011 Feb; 405(2):153-6. PubMed ID: 21232526
[TBL] [Abstract][Full Text] [Related]
36. Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma.
Moriya Y; Nohata N; Kinoshita T; Mutallip M; Okamoto T; Yoshida S; Suzuki M; Yoshino I; Seki N
J Hum Genet; 2012 Jan; 57(1):38-45. PubMed ID: 22089643
[TBL] [Abstract][Full Text] [Related]
37. The Role of miRNA-221 and miRNA-34a in Non-Melanoma Skin Cancer of the Head and Neck Region.
Tamas T; Raduly L; Berindan-Neagoe I; Dinu C; Botan E; Bumbu B; Tamas A; Stoia S; Leucuta DC; Bran S; Onisor F; Băciuț G; Armencea G; Băciuț M
Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833430
[TBL] [Abstract][Full Text] [Related]
38. Role of microRNAs in lung cancer: microRNA signatures in cancer prognosis.
Boeri M; Pastorino U; Sozzi G
Cancer J; 2012; 18(3):268-74. PubMed ID: 22647364
[TBL] [Abstract][Full Text] [Related]
39. Quantitative determination of the expression of xeroderma pigmentosum F gene in human nonmelanoma skin cancers.
Chang LC; Sheu HM; Huang YS; Kuo KW
Biochem Biophys Res Commun; 2000 Jul; 273(2):454-8. PubMed ID: 10873627
[TBL] [Abstract][Full Text] [Related]
40. MicroRNAs and human cancer.
Nikitina EG; Urazova LN; Stegny VN
Exp Oncol; 2012; 34(1):2-8. PubMed ID: 22453141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
